Fluent BioSciences: Funding, Investors & Team (Oct 2026)
Fluent Biosciences is a life science "single cell" technology company that offers molecular analysis of cells without the use of complex microfluidic instrumentation. The company’s proprietary platform, Pre-Templated Instant Partitions (PIPseqTM), provides instantaneous self-assembly of individual cells or molecules into millions of uniform partitions for sensitive, unbiased preparation of proteins and nucleic acids for sequencing applications. Fluent's technology expands accessibility of single cell, molecule, or protein analysis to every laboratory, enabling broader market access across all researchers in biotech, pharma, and academic centers.
Fluent BioSciences has raised $1.7M across 3 funding rounds on record, the most recent an undisclosed round announced in Mar 2024.
Fluent BioSciences Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Fluent BioSciences Funding Rounds
2 of 3 rounds were announced without a disclosed amount and are excluded from the total.
Fluent BioSciences raised $1.7M in a Grant announced in Mar 2022.
1.5 years later, an undisclosed round was announced in Sep 2023 with no disclosed amount.
6 months later, an undisclosed round was announced in Mar 2024 with no disclosed amount.
Fluent BioSciences Founders and Leadership Team
Contact details for the Fluent BioSciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Fluent BioSciences Funding Compared to Other Biotechnology Startups
Funded Startups Like Fluent BioSciences in Biotechnology and Watertown
Companies Similar to Fluent BioSciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Fluent BioSciences Funding FAQs
What does Fluent BioSciences do?
Fluent Biosciences is a life science "single cell" technology company that offers molecular analysis of cells without the use of complex microfluidic instrumentation. The company’s proprietary platform, Pre-Templated Instant Partitions (PIPseqTM), provides instantaneous self-assembly of individual cells or molecules into millions of uniform partitions for sensitive, unbiased preparation of proteins and nucleic acids for sequencing applications. Fluent's technology expands accessibility of single cell, molecule, or protein analysis to every laboratory, enabling broader market access across all researchers in biotech, pharma, and academic centers.
How much funding has Fluent BioSciences raised?
Fluent BioSciences has raised $1.7M across 3 rounds on record.
When did Fluent BioSciences last raise funding?
Fluent BioSciences' most recent funding round on record was announced in Mar 2024. The amount was not disclosed.
Who is the CEO of Fluent BioSciences?
Sepehr Kiani is listed as CEO at Fluent BioSciences.
Where is Fluent BioSciences headquartered?
Fluent BioSciences is based in Watertown, Massachusetts, United States.
How many employees does Fluent BioSciences have?
Fluent BioSciences is in the 11-50 employee band.
About FundedIQ's Fluent BioSciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fluent BioSciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.